Skip to content

Newrons Neuroscience

Active Private limited companyfounded 2025active for 1 yearBinnenstraat 19A, 3020 HerentKBO/BCE: BE 1023.970.107

Lifetime

1 annual account with figures
peak of €48,013 in 2025
€48,013 
peak of €5,970 in 2025
€5,970 
peak of €7,970 in 2025
€7,970 
€24,200 
Board1 name since 2025
1 director
Documentsfilings and deeds
02-07-202629 days before the deadline
2025micro format
Incorporation 06-061 establishment registeredFirst year with figures

Key points

from the 2025 annual accounts

Debts

€24,200 75% of the balance sheet
Suppliers 90%Taxes and wages 9%

Position in the sector

€7,970

Less equity than 89% of companies in human health. The sector median is €125,188, over 21,387 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,389 companies had the same profile as Newrons Neuroscience has now. Each dot stands for 6 companies, two years later.

96.6%
were still trading
2.1%
stopped another way
1.2%
went bankrupt
  • Micro
  • under 2 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more

Another 0.2% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,389 companies, not a prediction for Newrons Neuroscience. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 20 sharesdeed of 06-06-2025
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1023970107
Incorporation Founding capital of €2,000, 20 shares · Founded by · appointed as director · published on 06-06-2025 · Gazette deed
First establishment Binnenstraat 19A, Herent
All 4 events

Comparable companies

same main activity, similar in size and age
Company
Newrons Neuroscience Herent €32,170 €9,579 24.8% -
TERPSYCHORE Ixelles €38,061 €8,637 33.9% -
ELISA BERNARD Jemeppe-sur-Sambre €32,372 €12,295 5.1% -
DEWEZ GROUPE Anderlecht €30,561 €6,103 12.2% -
EssenSea Koksijde €21,141 €9,669 27.3% -
MT THERAPIE Braine-l'Alleud €27,520 €7,748 8.9% -
HET BLIJMOEDIGE MEER Scherpenheuvel-Zichem €31,465 €13,939 57.9% -

These companies have the same main activity as Newrons Neuroscience: psychology services (NACE 86931). They are comparable in size and age: total assets between €21,100 and €38,100, founded between 2024 and 2025.

Official details

Source: KBO
Status
Active since 04-06-2025Normal situation
Activity
Psychology servicesNACE 86931and 1 other
Establishment unit
2.374.930.3803020 Herent, since 04-06-2025
Financial year end
31 December
Peppol
Reachable since 19-11-2026
Company details

Annual accounts 2025

€32,170
Filing
Filed on 02-07-2026, 29 days before the end of the filing period
Financials

Insights on Newrons Neuroscience

Newrons Neuroscience has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €7,970 and a net result of €5,970.

Its solvency ranks better than 22% of 21,385 sector peers (NACE 86) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Newrons Neuroscience

What is the company number of Newrons Neuroscience?
The company number of Newrons Neuroscience is 1023.970.107. The VAT number is the same number with BE in front: BE 1023.970.107.
Where is Newrons Neuroscience based?
The registered office is at Binnenstraat 19A, 3020 Herent.Company details
What does Newrons Neuroscience do?
According to the KBO register, the main activity is psychology services (NACE 86931).
What is the legal form of Newrons Neuroscience?
Newrons Neuroscience is a private limited company (BV).
When was Newrons Neuroscience founded?
Newrons Neuroscience was founded on 04-06-2025.
Is Newrons Neuroscience still active?
Yes, Newrons Neuroscience is an active enterprise in the KBO register.
What is the turnover of Newrons Neuroscience?
The turnover of Newrons Neuroscience was €48,013 in financial year 2025, according to the filed annual accounts.Financials
Is Newrons Neuroscience profitable?
In financial year 2025, Newrons Neuroscience made a profit of €5,970.
Where can I find the annual accounts of Newrons Neuroscience?
Newrons Neuroscience filed 1 annual account with the National Bank of Belgium, for financial year 2025.
When are the next annual accounts of Newrons Neuroscience due?
Newrons Neuroscience must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.